Article History
Received: 18 January 2021
Accepted: 10 June 2021
First Online: 2 July 2021
Declarations
:
: MK and JEM have no disclosures to report. KK declares the following potential conflicts of interest: Medical Advisor—Immunomedics, Pfizer, Novartis, Eisai, Eli-Lilly, Amgen, Immunomedics, Merck, Seattle Genetics, and Astra Zeneca; Institutional Support—Immunomedics, Novartis, Incyte, Genentech/Roche, Eli-Lilly, Pfizer, Calithera Biosciences, Acetylon, Seattle Genetics, Amgen, Zentalis Pharmaceuticals, and CytomX Therapeutics; Speakers Bureau—Eli-Lilly; Spouse—Array Biopharma, Pfizer, Grail.